Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Cylene Pharmaceuticals identifies novel protein kinase inhibitors

Jan. 12, 2011

Antimalarial artesunate has anticancer properties that can be enhanced by combination therapy

Jan. 12, 2011

Enrollment begins in phase III regorafenib trial in gastrointestinal stromal tumors

Jan. 11, 2011

Eusa Pharma obtains FDA priority review status for Erwinaze BLA

Jan. 11, 2011

Abraxis claims new proto-oncogene tyrosine-protein kinase Src inhibitors

Jan. 11, 2011

TopoTarget patents new NAmPRTase inhibitors

Jan. 11, 2011

Inhibition of HSP 90 is efficacious in MET-amplified tumor cells

Jan. 10, 2011

Apaziquone enters Japanese phase I trial in bladder cancer

Jan. 10, 2011

First-in-human study evaluates multikinase inhibitor 4SC-203

Jan. 10, 2011

Clinical trial verifies mechanism of antisense oligonucleotide LY-2181308

Jan. 10, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...